GHK tripeptide sequesters acrolein via multi-site conjugation, neutralizing carbonyl toxin
Background
Acrolein (ACR) is a reactive carbonyl species generated by lipid peroxidation of polyunsaturated fatty acids and is mechanistically linked to Alzheimer's disease, arteriosclerosis, diabetes, and nephropathy. Carbonyl stress — the accumulation of reactive aldehydes that modify biomolecules — represents a shared upstream driver in these pathologies, yet few endogenous quenching mechanisms have been fully characterized. GHK (glycyl-histidyl-lysine) is an endogenous tripeptide isolated from human plasma and known as a liver cell growth factor, but its capacity to neutralize electrophilic aldehydes like ACR had never been demonstrated prior to this work. Understanding how GHK intercepts Michael acceptors such as ACR could reframe its physiological role and open new avenues for carbonyl-stress-linked disease prevention.
Study Design
Researchers reacted ACR (30 µM) with GHK at four concentrations (0.1, 0.25, 0.5, and 1.0 mM) in phosphate buffer at pH 7.4. Aldehyde consumption was tracked over time by reverse-phase HPLC. After 4 hours, when ACR had fully disappeared, reaction products from a 1:1 GHK:ACR molar ratio were profiled using ESI-MS/MS direct infusion experiments in positive ion mode. Theoretical calculations were also employed to support structural characterization of the conjugation products.
Results
Multiple distinct conjugation products were detected in the GHK + ACR (1:1) reaction, indicating a complex, sequential reaction cascade rather than a single adduct. ACR added to GHK in a stepwise manner, with up to 3 moles of ACR incorporating into a single GHK molecule. The primary sites of attack were the ε-amino group of the lysine residue and the N(tau) and N(pi) nitrogen atoms of the histidine imidazole ring. At the lysine site, a Michael addition of two ACR molecules to the ε-amino group was followed by aldol condensation and dehydration, yielding the structurally defined N-(3-formyl-3,4-dehydropiperidino) derivative — a well-characterized ACR cross-linking product.
The most structurally significant finding was that sequential Michael addition of two ACR molecules to the lysine ε-amino group drives aldol condensation and dehydration, producing the N-(3-formyl-3,4-dehydropiperidino) adduct — confirming GHK as a bona fide multi-site ACR quencher.
Histidine nitrogen atoms provided additional reactive sites, expanding the quenching capacity of the tripeptide beyond lysine alone. The ESI-MS/MS direct-infusion approach enabled rapid profiling of the full product spectrum, validating the method for carbonyl-trapping studies.
Key Findings
- ACR (30 µM) was fully consumed by GHK within 4 hours at pH 7.4.
- Up to 3 moles of ACR incorporated sequentially into a single GHK molecule.
- Two ACR molecules reacted with the lysine ε-amino group via Michael addition, then underwent aldol condensation and dehydration to form the N-(3-formyl-3,4-dehydropiperidino) derivative.
- Histidine N(tau) and N(pi) nitrogens served as additional ACR conjugation sites.
- ESI-MS/MS direct infusion enabled rapid profiling of all GHK+ACR reaction products.
Why It Matters
GHK's newly characterized role as an ACR quencher suggests its endogenous presence in plasma may serve a direct cytoprotective function against carbonyl stress — a mechanism previously unrecognized for this peptide. For clinicians and researchers targeting Alzheimer's disease, arteriosclerosis, diabetes, or nephropathy, these findings position GHK as a candidate pharmacological tool for intercepting ACR-driven molecular damage upstream of disease progression. The practical implication is that GHK supplementation could theoretically reduce the burden of ACR-modified proteins in tissues where lipid peroxidation is elevated, though translation from a chemistry reaction at pH 7.4 to an in vivo therapeutic effect requires substantial further work. The multi-site reactivity — both lysine and histidine — also means dosing adequacy would need to account for the stoichiometric consumption of GHK by ACR at a ratio that may reach 1:3.
